Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT05667194
Brief Summary:
KH617 is a injection used for advanced solid tumors which must be diluted with 5% Dextrose Injection.
Study:
NCT05667194
Study Brief:
Protocol Section:
NCT05667194